📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Low-dose methotrexate in myeloproliferative neoplasm models. (2017)

First Author: Chinnaiya K

Attributed to: Wellcome Trust MRC Cambridge Stem Cell Institute funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.3324/haematol.2017.165738

PubMed Identifier: 28550185

Publication URI: http://europepmc.org/abstract/MED/28550185

Type: Journal Article/Review

Volume: 102

Parent Publication: Haematologica

Issue: 9

ISSN: 0390-6078